Participation in cervical cancer screening by age and region - A cohort study with a 3 1/2 year follow-up on 2 223 135 women in Bavaria;Teilnahme an früherkennungsuntersuchungen für zervixkarzinom nach alter und region: Eine kohortenstudie mit 2 223 135 frauen in Bayern

Gesundheitswesen

Volumn 70, Issue 6, 2008, Pages 357-359

  Ruckinger S ^a   Tauscher, M ^b   Redel, R ^b   Munte, A ^b   Walchner Bonjean, M ^c   Hess, J ^c   Schneider, A ^d   Von Kries, R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Kassenarztliche Vereinigung Bayerns   (Germany)

^c BKK Landesverband Bayern   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cervical cancer; Participation; Screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; COHORT ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; MAJOR CLINICAL STUDY; RURAL AREA; UTERINE CERVIX CANCER; AGE DISTRIBUTION; FOLLOW UP; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATIENT PARTICIPATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICS; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; WOMEN'S HEALTH;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MASS SCREENING; MIDDLE AGED; PATIENT PARTICIPATION; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH;

EID: 49449109912     PISSN: 09413790     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1065364     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
2. Ferlay J BF, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence. Mortality and Prevalence Worldwide. IARC CancerBase No 5, version 20. Lyon: IARC Press 2004
3. Anttila A, Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer 2000; 36: 2209-2214
4. Arbyn M, Oyen H Van. Cervical cancer screening in Belgium. Eur J Cancer 2000; 36: 2191-2197
5. Bigaard J, Hariri J, Lynge E. Cervical cancer screening in Denmark. Eur J Cancer 2000; 36: 2198-2204
6. Breitenecker G, Wiener H, Stani J. Cervical cancer screening in Austria. Eur J Cancer 2000; 36: 2189-2190
7. Dillner J. Cervical cancer screening in Sweden. Eur J Cancer 2000; 36: 2255-2259
8. Fernandez Calvo MT, Hernandez Rubio A, Rosell Aguilar I. Cervical cancer screening in Spain. Eur J Cancer 2000; 36: 2250-2254
9. O'Neill W. Cervical cancer screening in Ireland. Eur J Cancer 2000; 36: 2233-2234
10. Patnick J. Cervical cancer screening in England. Eur J Cancer 2000; 36: 2205-2208
11. Real O, Silva D, Leitao MA, Oliveira HM, Rocha Alves JG. Cervical cancer screening in the central region of Portugal. Eur J Cancer 2000; 36: 2247-2249
12. Riza E, Kyriakogianni-Psaropoulou P, Koumantakis E et al. Cervical cancer screening in Greece. Eur J Cancer 2000; 36: 2227-2232
13. Schaffer P, Sancho-Garnier H, Fender M et al. Cervical cancer screening in France. Eur J Cancer 2000; 36: 2215-2220
14. Scheiden R, Knolle U, Wagener C, Wehenkel AM, Capesius C. Cervical cancer screening in Luxembourg. Eur J Cancer 2000; 36: 2240-2243
15. Schenck U, Karsa L von. Cervical cancer screening in Germany. Eur J Cancer 2000; 36: 2221-2226
16. Segnan N, Ronco G, Ciatto S. Cervical cancer screening in Italy. Eur J Cancer 2000; 36: 2235-2239
17. Ballegooijen M van, Hermens R. Cervical cancer screening in the Netherlands. Eur J Cancer 2000; 36: 2244-2246
18. Linos A, Riza E. Comparisons of cervical cancer screening programmes in the European Union. Eur J Cancer 2000; 36: 2260-2265
19. Anttila A, Ronco G, Clifford G et al. Cervical cancer screening programmes and policies in 18 European countries. Br J Cancer 2004; 91: 935-941
20. Junge B A-KL, Tiefelsdorfer M, Hoffmeister H. Krebsfrü herkennung wird zu wenig genutzt-Repräsentative Ergebnisse aus dem Nationalen Gesundheits-Survey. Zeitschrift für Allgemeinmedizin 1992; 68: 816
21. Kassenärztliche-Bundesvereinigung Beteiligung an den Früherkennungsuntersuchungen in der GKV seit 1972. Grunddaten zur vertragsärztlichen Versorgung in der Bundesrepublik Deutschland 1999. Fachbereich Bedarfsplanung und Bundesarztregister 1999
22. Robra BP, Dierks ML. Development of the participation in early cancer screening of women. Gynakologe 1990; 23: 308-311
23. Klug SJ, Hetzer M, Blettner M. Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors. Eur J Public Health 2005; 15: 70-77
24. Bayerisches-Landesamt-für-Statistik-und-Datenverarbeitung GENESIS-Online - Statistisches Informationssystem Bayern
25. Schneider A, Hoyer H, Lotz B et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 2000; 89: 529-534
26. Schneider A, Zahm DM, Kirchmayr R, Schneider VL. Screening for cervical intraepithelial neoplasia grade 2/3: validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol 1996; 174: 1534-1541
27. Nanda K, MacCrory DC, Myers ER et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000; 132: 810-819